These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Influence of Opa1 Mutation on Survival and Function of Retinal Ganglion Cells. González-Menéndez I; Reinhard K; Tolivia J; Wissinger B; Münch TA Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4835-45. PubMed ID: 26218912 [TBL] [Abstract][Full Text] [Related]
11. Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy. Yu-Wai-Man P; Davies VJ; Piechota MJ; Cree LM; Votruba M; Chinnery PF Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4561-6. PubMed ID: 19443720 [TBL] [Abstract][Full Text] [Related]
12. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model. Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463 [TBL] [Abstract][Full Text] [Related]
13. Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation. Chun BY; Rizzo JF Curr Opin Ophthalmol; 2016 Nov; 27(6):475-480. PubMed ID: 27585216 [TBL] [Abstract][Full Text] [Related]
15. OPA1: How much do we know to approach therapy? Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676 [TBL] [Abstract][Full Text] [Related]
16. Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the García-López M; Jiménez-Vicente L; González-Jabardo R; Dorado H; Gómez-Manjón I; Martín MÁ; Ayuso C; Arenas J; Gallardo ME Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000346 [TBL] [Abstract][Full Text] [Related]
17. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Williams PA; Morgan JE; Votruba M Brain; 2010 Oct; 133(10):2942-51. PubMed ID: 20817698 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency. Kushnareva Y; Seong Y; Andreyev AY; Kuwana T; Kiosses WB; Votruba M; Newmeyer DD Cell Death Dis; 2016 Jul; 7(7):e2309. PubMed ID: 27468686 [TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function. Smith TG; Seto S; Ganne P; Votruba M Neuroscience; 2016 Apr; 319():92-106. PubMed ID: 26820596 [TBL] [Abstract][Full Text] [Related]
20. OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy. White KE; Davies VJ; Hogan VE; Piechota MJ; Nichols PP; Turnbull DM; Votruba M Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2567-71. PubMed ID: 19234344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]